中 / EN

Clinical Translation

64 entries

Clinical translation is the critical phase bridging BCI research and patient care, involving regulatory approvals, trial design, long-term safety assessment, and commercialization. This topic covers FDA and NMPA regulatory updates, Breakthrough Device designations, and the journey from first-in-human trials to market.

July 2026
07-28 · imec Belgium Industry News Progress & Expansion

Neurotech Leaders Forum Returns to imec With Europe at an Inflection Point

The second annual Neurotech Leaders Forum drew executives, investors, researchers and regulators from Europe and the United States to imec's campus in Leuven, Belgium, on June 23-24, 2026, for sessions on clinical translation, capital formation, regulatory strategy and emerging frontiers. Thomas Stieglitz of the University of Freiburg gave the Day 1 keynote, arguing for perseverance and functionalist design, and later sessions covered women's health, European BCI ventures and the region's capital and regulatory challenges. Companies showing new work included WISE SpA, with its Heron spinal cord stimulation lead, and Melora Medical, with a transcutaneous auricular vagus nerve stimulation (taVNS) device for dermatology.
View details →
07-27 · NeuroXess China Policy & Regulation Regulatory Approval

NeuroXess 'Sanquan' BCI Enters CMDE Innovative Medical Device Review Program

NeuroXess announced that its self-developed implantable brain-computer interface system for hand motor function compensation — the 'fully implanted, fully wireless, fully functional' ('Sanquan') system — has passed public notice and formally entered the innovative medical device special review program of the National Medical Products Administration's Center for Medical Device Evaluation (CMDE), commonly known as the green channel. The company describes it as the first subdural implantable flexible BCI product in China to enter the program. The system began a GCP registration clinical trial at Huashan Hospital, Fudan University on July 7, 2026, run as a multicentre study across 15 Class III hospitals nationwide, with trial data intended to support a Class III medical device registration application with the NMPA. The system remains in the review and clinical-trial stage and has not yet been approved for market; the registration timeline reflects company statements and remains subject to regulatory notice.
View details →
07-24 · Central Michigan University +1 more United States Papers Foundations & Methods

Only 11 pediatric BCI trials worldwide, children may be underrepresented

A registry-based cross-sectional analysis found only 11 pediatric brain-computer interface (pBCI) clinical trials worldwide, spanning 7 countries. Eight evaluated non-implanted devices and 3 evaluated implanted systems. Non-implanted trials had a median enrollment of 29 participants and median duration of 56.0 days; implanted trials had a median enrollment of 8 and median duration of 365.3 days. Only 4 studies enrolled exclusively pediatric participants; the rest recruited both children and adults. The authors conclude that current pBCI research is limited in scope and that children may be inadequately prioritized.
View details →
07-24 Papers Foundations & Methods

BCI Paradigm Measures Auditory Frequency Discrimination Without Behavioral Reports

Researchers ran 11 healthy participants through a personalized rapid serial auditory presentation paradigm and decoded the resulting weak auditory evoked responses trial by trial with a new model, the Multi-Scale Spatial-Temporal Dual Attention Network (MS-STAMNet), reaching an unweighted average recall of 69.67±6.12% and an AUC of 0.7618±0.07, ahead of the EEGNet and PLNet baselines. Conventional measurement of the auditory frequency difference limen (FDL) depends on participants actively reporting what they hear, which leaves it open to subjective bias. Regression analysis found that neural decoding and behavioral performance came apart, suggesting the model picks up frequency deviations too small to reach conscious report.
View details →
07-18 Papers Foundations & Methods

Preprint: Cross-Subject Learning Cuts BCI Calibration for Children With Cerebral Palsy

A preprint reports that cross-subject cumulative learning and transfer learning can sharply cut the calibration burden of brain-computer interfaces based on movement-related cortical potentials (MRCP) in children with cerebral palsy. Testing a bidirectional long short-term memory network across 27 training sessions in four children, the authors found cross-subject cumulative learning reached 91% accuracy with no within-session calibration, rising to 93% when transfer learning was added — both better than conventional calibration strategies.
View details →
07-17 · Inner Mongolia Medical University China Industry News Progress & Expansion

Inner Mongolia Opens First BCI Hospital Ward

The first brain-computer interface hospital ward in China's Inner Mongolia autonomous region was unveiled in Hohhot, CCTV.com reported on July 17, 2026. At the unveiling ceremony, Hurile, head of the rehabilitation medicine department at Inner Mongolia Medical University, delivered a briefing introducing the ward's construction, technical strengths and development plans, framing the ward as a starting point for building a new clinical rehabilitation ecosystem in the autonomous region. The report did not disclose the ward's bed capacity, equipment, patient scope or opening date, nor the full name of the hospital housing the ward.
View details →
07-15 Papers Foundations & Methods

MOJO Framework Boosts Neural Decoder Accuracy When Labels Are Scarce

Researchers have proposed MOJO, a training scheme that pairs masked autoencoding with a supervised objective for decoders that tokenize spiking activity. Tested on monkey motor cortex, multi-region mouse recordings and human electrocorticography during speech, MOJO beat purely supervised models, with the widest margins in few-shot finetuning where labels were limited, and produced more interpretable neuronal representations. The paper, posted to arXiv on July 15, 2026, has not been peer reviewed.
View details →
07-15 · Carnegie Mellon University United States Papers Foundations & Methods

Carnegie Mellon's Sensory-Guided Training Speeds Motor Imagery BCI Learning

Carnegie Mellon University researchers report a sensory-guided joint learning framework that pairs human motor learning with adaptive machine learning to train motor imagery BCI users. Across 31 BCI-naive participants, average online discrete accuracy was 86.0% in one dimension and 77.5% in two, with continuous control accuracy at 77.5% and 66.9% respectively; tactile guidance reduced how much users had to explore and accelerated neural adaptation, while sample reweighting kept decoder updates aligned with the learner's own trajectory. The authors frame the approach as a shift from passive calibration to active human-machine joint learning; the study appears in Nature Communications.
View details →
07-08 · Health Commission of Shandong Province China Policy & Regulation Industrial Planning

Shandong Bids to Be China BCI Testing Hub

Sixteen departments in China's Shandong province, led by the Health Commission, issued the Work Plan for Accelerating Clinical Translation and Application Innovation of Brain-Computer Interfaces, document number Lu Wei Yi Zi [2026] No. 13, dated July 7, 2026 and released on July 8. It is the only provincial BCI document led by a health authority and Shandong's second after the science department's industry plan. The plan advances a positioning it summarises as validated in Shandong, applied globally, working through an alliance, scenarios, policy and industry follow-through. Targets rise in four steps: an operating clinical research alliance in 2026; about 20 core technology breakthroughs and 30 technology SMEs by 2027; at least 30 alliance members, more than 20 foreign and domestic teams setting up validation bases, more than 30 multicentre projects and a 2 billion yuan industry by 2028; and a national validation cluster by 2030.
View details →
07-07 · Paradromics United States Media Coverage Progress & Expansion

Paradromics Names William Marks Chief Clinical Officer as Connexus Study Advances

Paradromics has named William J. Marks chief clinical officer; he brings nearly three decades of experience in clinical neuroscience and implantable devices. The appointment comes as the company advances Connect-One, an early feasibility study of its Connexus BCI system, which is intended to restore communication for people who have lost it to spinal cord injury, stroke or ALS.
View details →
07-02 China Clinical Launch & Registration

Beijing Tongren Hospital Registers Observational Study of Clinical Needs for Invasive Visual BCI

The study involves no implant and tests no device. It asks 50 adults with acquired blindness what existing assistive devices get wrong, and what they would want from a vision-restoration implant. Outcomes span demographics and economics, quality of life, clinical features, satisfaction with current aids, and design requirements for an invasive visual brain-computer interface. Participants must be at least 18, have only weak or no light perception in both eyes, and have lost their sight after birth; congenital blindness is excluded.
View details →
07-02 · BIOSerenity France Papers Foundations & Methods

BIOSerenity's E1 Foundation Model Posts Strong Results on Four Clinical EEG Tasks

French medtech company BIOSerenity has built an EEG foundation model, BIOSerenity-E1, pre-trained self-supervised on more than 4,000 hours of recordings, and reports strong results on four clinical tasks: normal/abnormal classification, Alzheimer's disease detection, pediatric sleep staging and seizure detection. The normal/abnormal algorithm is already built into a CE-marked medical device, and the seizure-detection algorithm is in clinical evaluation. The work will be shown as a poster at the 8th Journées de Neurophysiologie Clinique in Grenoble, France.
View details →
June 2026
May 2026
05-27 China Clinical Launch & Registration

Xuanwu Hospital Registers BCI Rehabilitation Trial Enrolling 58 Stroke Patients

The randomized controlled trial plans to enroll 58 patients with upper limb motor dysfunction after stroke. The test group will receive feedback-based rehabilitation training through brain-computer interface interaction, while the control group will undergo traditional upper limb circular motion training. The primary outcome is the Fugl-Meyer Motor Assessment-Upper Extremity (FMA-UE), with secondary outcomes covering motor function, daily living activities, quality of life and neurophysiological measures including EEG, transcranial magnetic stimulation and fNIRS. The trial was prospectively registered, with first enrolment set for June 1, 2026, and recruitment has not yet started.
View details →
05-26 · Jiangxi Provincial Health Commission China Policy & Regulation Ethics & Governance

Jiangxi Sets 10-Day Clock on BCI Ethics Review

The Jiangxi Provincial Health Commission in eastern China issued Guidelines for Ethics Review of Brain-Computer Interface Clinical Research Projects on May 26, 2026, document number Gan Wei Ke Jiao Fa [2026] No. 8, providing implementing detail for the mutual recognition mechanism proposed in the province's November 2025 BCI measures. For multicentre projects the lead institution's ethics committee conducts the first full review; participating institutions should finish within 10 working days of receiving complete materials and examine only local research conditions, staff qualifications and the informed-consent process; and the lead institution must file with the provincial medical ethics expert committee within 10 working days. Invasive projects treating neurological or psychiatric disease need provincial committee review within 20 working days, with an opinion issued within a further seven.
View details →
05-26 China Clinical Launch & Registration

Xi'an Jiaotong University Second Hospital Registers BCI Lower-Limb Stroke Trial for 222 Patients

The multicenter randomized controlled trial plans to enroll 222 patients who are 1 to 3 months past their first stroke and have motor impairment in the affected lower limb. The experimental group will receive 4 weeks of motor imagery-based BCI-driven active and passive lower limb training, while the control group gets 4 weeks of conventional training. The primary outcome is the Fugl-Meyer Assessment Lower Extremity Section, with balance, daily living ability and walking classification as secondary outcomes. First enrolment is set for May 31, 2026.
View details →
05-22 China Clinical Launch & Registration

China Registers Trial of Multimodal BCI for Early Alzheimer's Screening

A Chinese team has registered a clinical trial of a multimodal brain-computer interface system for intelligent diagnosis and treatment, aimed at early screening and non-invasive modulation of Alzheimer's disease. The entry, ChiCTR2600125240, was filed with the Chinese Clinical Trial Registry on May 22, 2026 and is carried by the WHO International Clinical Trials Registry Platform; recruitment has not begun.
View details →
05-20 China Clinical Launch & Registration

Xi'an Jiaotong University First Affiliated Hospital Registers Multicenter Trial of SSVEP-BCI-Driven Stimulation for Post-Stroke Dysphagia

The trial tests whether a steady-state visual evoked potential (SSVEP) brain-computer interface can drive functional electrical stimulation of swallowing muscles more effectively than conventional neuromuscular electrical stimulation. It plans to enroll 90 patients, 45 per arm, all within 6 months of a first ischemic or hemorrhagic stroke and aged 18 to 80. The primary outcome is the Standard Swallowing Assessment, with secondary measures including the Functional Oral Intake Scale and the Penetration-Aspiration Scale. First enrollment is listed for June 1, 2026.
View details →
05-20 China Clinical Launch & Registration

Shanghai Ninth People's Hospital Registers BCI Trial in Burning Mouth Syndrome, Plans 38 Participants

Burning mouth syndrome produces months or years of burning oral pain with no visible lesion on examination, and treatment options are limited, leaving patients shuttling between oral medicine and psychiatry. A randomized, sham-controlled interventional trial registered by Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, will apply transcranial direct current stimulation over the left dorsolateral prefrontal cortex while collecting resting-state brain function and structural imaging, tracking pain, anxiety, depression, sleep and salivary flow. The trial is funded by the hospital's Brain-Computer Interface Special Research Program and registered as ChiCTR2600124987 on May 20, 2026. It plans to enroll 38 participants, 19 in the active group and 19 in the sham group, with first enrollment set for June 1, 2026; recruitment has not yet started.
View details →
05-08 China Clinical Launch & Registration

Binzhou Medical University Hospital Registers BCI Plus Electrical Stimulation Trial in Parkinson's Disease

The trial plans to enroll 40 patients with Parkinson's disease aged 40 to 80, randomized into 2 groups: one adds brain-computer interface rehabilitation training to functional electrical stimulation, the other receives functional electrical stimulation alone. Both arms train 20 minutes per day for the upper extremities and 20 minutes per day for the lower extremities, completing 12 treatment days within 2 weeks. The primary endpoint is a motor symptom rating scale, with diffusion tensor imaging, magnetic resonance spectroscopy, resting-state fMRI, and sleep, cognitive and mood scales as secondary endpoints, testing whether adding BCI training produces measurable change beyond motor symptoms.
View details →
05-07 China Clinical Launch & Registration

ChiCTR Registers Trial of BCI Plus tDCS in Disorders of Consciousness

A trial testing a brain-computer interface (BCI) combined with transcranial direct current stimulation (tDCS) in patients with disorders of consciousness was registered with the Chinese Clinical Trial Registry (ChiCTR) on May 7, 2026 under the number ChiCTR2600124127, and is now recruiting. The design, sample size and sponsor are not given in the record and would have to be checked against the original registration.
View details →
April 2026
04-30 China Clinical Launch & Registration

Bengbu Medical University Hospital Registers Multicenter Trial of MRI-Guided Temporal Interference Stimulation for Refractory Migraine

A randomized, sham-controlled trial will pair a non-invasive brain-computer interface with MRI-guided multichannel temporal interference stimulation in patients whose migraines resist medication. It plans to enroll 78 people aged 18 to 65, split evenly between real and sham stimulation, with headache frequency as the primary endpoint. The registration lists only design and bibliographic fields, so device details and actual enrollment remain unknown and efficacy has yet to be read out.
View details →
04-27 China Clinical Launch & Registration

ChiCTR Registers Trial of Early BCI Training After Stroke Reperfusion

The Chinese Clinical Trial Registry (ChiCTR) has logged a study of the safety and efficacy of early brain-computer interface training given after reperfusion therapy in patients with acute ischemic stroke, an attempt to pin down when in the recovery window such training should start. Registered on April 27, 2026 as ChiCTR2600123548, the trial has not begun recruiting, and design, sample size and sponsor are absent from the record carried by the WHO International Clinical Trials Registry Platform (ICTRP) and must be read from the original registration.
View details →
04-13 China Clinical Launch & Registration

BCI-Guided Mindfulness Training Registered in Trial for Adolescent Depression

A trial registered in China pairs brain-computer interface technology with mindfulness meditation training for adolescents with depression, recording EEG alongside the sessions to see how brain activity changes. The question is whether real-time brain signals can be read during meditation and fed back into the training, making the intervention more responsive to each participant's state. Recruitment has not yet started, and the design, sample size and sponsor have not been disclosed.
View details →
March 2026
03-23 China Clinical Launch & Registration

China Trial Registry Lists BCI Study for Post-Stroke Functional Recovery

A new entry in the Chinese Clinical Trial Registry covers a study using brain-computer interface technology for functional recovery after stroke. The record, ChiCTR2600120924, was posted on March 23, 2026, and lists its status as not yet recruiting. The registry listing carries only bibliographic details, so the trial design, sample size and sponsor remain undisclosed.
View details →
February 2026
January 2026
01-11 United States Policy & Regulation Regulatory Approval

Alphatec Spine's SafeOp 3 Neural Monitoring System Clears FDA 510(k)

Alphatec Spine's SafeOp 3 neural monitoring system received FDA 510(k) clearance on January 11, 2026 for intraoperative neural monitoring. The device is regulated as a Class II "Stimulator, Electrical, Evoked Response" under regulation number 882.1870, and the clearance came through the traditional 510(k) pathway, with the FDA finding the device substantially equivalent to a predicate device. Alphatec Spine, a maker of spinal surgery devices and technologies, adds SafeOp 3 to its neural monitoring portfolio; the system is intended to let surgeons assess nerve function in real time during procedures and lower the risk of nerve injury.
View details →
September 2025
09-05 · Huazhong University of Science and Technology +1 more China Industry News Progress & Expansion

Chinese Hospital Opens Its Own Brain-Computer Interface Research Institute

Tongji Hospital in Wuhan announced a brain-computer interface research institute on 5 September 2025, which it says is the first of its kind run by a hospital in China rather than by a university or a company. The institute covers basic research, clinical application and commercialisation, with the stated aim of building a full-chain BCI system spanning prevention, diagnosis, treatment and rehabilitation of neurological disease.
View details →
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About